Lantibiotics: Structure, biosynthesis and mode of action

FEMS Microbiology Reviews

Volumn 25, Issue 3, 2001, Pages 285-308

  McAuliffe, Olivia ^a   Ross, R Paul ^b   Hill, Colin ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b TEAGASC   (Ireland)

Author keywords

Bacteriocin; Lacticin 3147; Lantibiotic; Mode of action; Nisin

Indexed keywords

ACTAGARDIN; ANCOVENIN; BACTERIOCIN; CARNOCIN U149; CYPEMYCIN; CYTOLYSIN; DURAMYCIN B; DURAMYCIN C; EPICIDIN 280; EPIDERMIN; EPILANCIN K7; GALLIDERMIN; LACTICIN 3147; LACTICIN 481; LACTOCIN S; LANTHIOPEPTIN; LANTIBIOTIC; MERSACIDIN; MUTACIN B; NISIN A; NISIN Z; PEP5; SALVARICIN A; STAPHYLOCOCCIN C55; STREPTOCOCCIN A FF2; SUBLANCIN 168; SUBTILIN; UNCLASSIFIED DRUG; VARIACIN 8;

AUTOREGULATION; BIOSYNTHESIS; CHANNEL GATING; CHEMICAL STRUCTURE; DECARBOXYLATION; GENE CLUSTER; IMMUNITY; MEMBRANE COMPONENT; NONHUMAN; PROTEIN DEGRADATION; REACTION ANALYSIS; REVIEW; RNA TRANSLATION;

ALANINE; AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIOCINS; MOLECULAR SEQUENCE DATA; PEPTIDES; SULFIDES;

EID: 0035004672     PISSN: 01686445     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-6445(00)00065-6     Document Type: Review

References (233)

1. Lindgren S.E., Dobrogosz W.J. Antagonistic activities of lactic acid bacteria in food and feed fermentations. FEMS Microbiol. Rev. 87:1990;149-164.
2. Ray, B. and Daeschel, M. (1992) Food biopreservatives of microbial origin. CRC Press, Boca Raton, FL.
3. Abee T. Pore-forming bacteriocins of Gram-positive bacteria and self-protection mechanisms of producer organisms. FEMS Microbiol. Lett. 129:1995;1-10.
4. Stiles M.E. Biopreservation by lactic acid bacteria. Antonie van Leeuwenhoek. 70:1996;331-345.
5. Rogers L.A. The inhibiting effect of Streptococcus lactis on Lactobacillus bulgaricus. J. Bacteriol. 16:1928;321-325.
6. Tagg J.R., Dajani A.S., Wannamaker L.W. Bacteriocins of Gram-positive bacteria. Microbiol. Rev. 40:1976;722-756.
7. Klaenhammer T.R. Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol. Rev. 12:1993;39-86.
8. Guder A., Wiedemann I., Sahl H.-G. Post-translationally modified bacteriocins - the lantibiotics. Biopolymers. 55:2000;62-73.
9. van Kraaij C., de Vos W.M., Siezen R.J., Kuipers O.P. Lantibiotics: biosynthesis, mode of action and applications. Nat. Prod. Rep. 16:1999;575-587.
10. Gross E., Morell J.L. The structure of nisin. J. Am. Chem. Soc. 93:1971;4634-4635.
11. Piard J.-C., Kuipers O.P., Rollema H.S., Desmazeuad M.J., de Vos W.M. Structure, organization and expression of the lct gene for lacticin 481, a novel lantibiotic produced by Lactococcus lactis. J. Biol. Chem. 268:1993;16361-16368.
12. Gilmore M.S., Segarra R.A., Booth M.C. An HlyB-type function is required for expression of the Enterococcus faecalis hemolysin/bacteriocin. Infect. Immun. 58:1990;3914-3923.
13. Ryan M.P., Jack R.W., Josten M., Sahl H.-G., Jung G., Ross R.P., Hill C. Extensive-translational modification, including a serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147. J. Biol. Chem. 274:1999;37544-37550.
14. Navaratna M.A.D.B., Sahl H.-G., Tagg J.R. Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Appl. Environ. Microbiol. 64:1998;4803-4808.
15. Henderson J.T., Chopko A.L., van Wassenaar P.D. Purification and primary structure of pediocin PA-1 produced by Pediococcus acidilactici PAC-1.0. Arch. Biochem. Biophys. 295:1992;5-12.
16. Holck A.L., Axelsson L., Birkeland S., Aukrust T., Blom H. Purification and amino acid sequence of sakacin A, a bacteriocin from Lactobacillus sake Lb706. J. Gen. Microbiol. 138:1992;2715-2720.
17. Aymerich T., Holo H., Håvarstein L.S., Hugas M., Garriga M., Nes I.F. Biochemical and genetic characterization of enterocin A from Enterococcus faecium, a new antilisterial bacteriocin in the pediocin family of bacteriocins. Appl. Environ. Microbiol. 62:1996;1676-1682.
18. Nissen-Meyer J., Holo H., Håvarstein L.S., Sletten K., Nes I.F. A novel lactococcal bacteriocin whose activity depends on the complementary action of two peptides. J. Bacteriol. 174:1992;5686-5692.
19. Muriana P.M., Klaenhammer T.R. Cloning, phenotypic expression, and DNA sequence of the gene for lacticin F, an antimicrobial peptide produced by Lactobacillus spp. J. Bacteriol. 173:1991;1779-1788.
20. Muriana P.M., Klaenhammer T.R. Purification and partial characterization of lacticin F, a bacteriocin produced by Lactobacillus acidophilus 11088. Appl. Environ. Microbiol. 57:1991;114-121.
21. Leer R.J., van der Vossen J.M.B.M., van Giezen M., van Noort J.M., Pouwels P.H. Genetic analysis of acidocin B, a novel bacteriocin produced by Lactobacillus acidophilus. Microbiology. 141:1995;1629-1635.
22. Joerger M.C., Klaenhammer T.R. Characterization and purification of helveticin J and evidence for a chromosomally determined bacteriocin produced by Lactobacillus heleveticus 481. J. Bacteriol. 167:1986;439-446.
23. Jimenez-Diaz R., Ruiz-Barba J.L., Cathcart D.P., Holo H., Nes I.F., Sletten K.H., Warner P.J. Purification and partial amino acid sequence of plantaricin S, a bacteriocin produced by Lactobacillus plantarum LPCO10, the activity of which depends on the complementary action of two peptides. Appl. Environ. Microbiol. 61:1995;4459-4463.
24. Nes I.F., Holo H. Class II antimicrobial peptides from lactic acid bacteria. Biopolymers. 55:2000;50-61.
25. Sablon E., Contreras B., Vandamme E. Antimicrobial peptides of lactic acid bacteria: mode of action, genetics and biosynthesis. Adv. Biochem. Eng. Biotechnol. 68:2000;21-60.
26. Ennahar S., Sashihara T., Sonomoto K., Ishizaki A. Class IIa bacteriocins: biosynthesis, structure and activity. FEMS Microbiol. Rev. 24:2000;85-106.
27. O'Keeffe, T. (1998) Molecular characterisation of enterocin A (1146), an inducible bacteriocin produced by Enterococcus faecium, Ph.D. thesis. National University of Ireland.
28. Boman H.G. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol. 13:1995;61-92.
29. Nissen-Meyer J., Nes I.F. Ribosomally synthesized antimicrobial peptides: their function, structure, biogenesis, and mechanism of action. Arch. Microbiol. 167:1997;67-77.
30. de Vos W.M., Kuipers O.P., van der Meer J.R., Siezen R.J. Maturation pathway of nisin and other lantibiotics: post-translationally modified antimicrobial peptides exported by Gram-positive bacteria. Mol. Microbiol. 17:1995;427-437.
31. Sahl H.-G., Jack R.W., Bierbaum G. Biosynthesis and biological activities of lantibiotics with unique post-translational modifications. Eur. J. Biochem. 230:1995;827-853.
32. Sahl H.-G., Bierbaum G. Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from Gram-positive bacteria. Annu. Rev. Microbiol. 52:1998;41-79.
33. Jack R.W., Sahl H.-G. Unique peptide modifications involved in the biosynthesis of lantibiotics. Trends. Biotechnol. 13:1995;269-278.
34. Mulders J.W.M., Boerrigter I.J., Rollema H.S., Siezen R.J., de Vos W.M. Identification and characterization of the lantibiotic nisin Z, a natural nisin variant. Eur. J. Biochem. 201:1991;581-584.
35. de Vos W.M., Mulders J.W.M., Siezen R.J., Hugenholtz J., Kuipers O.P. Properties of nisin Z and distribution of its gene, nisZ, in Lactococcus lactis. Appl. Environ. Microbiol. 59:1993;213-218.
36. Gross E., Kiltz H. The number and nature of α,β-unsaturated amino acids in subtilin. Biochem. Biophys. Res. Commun. 50:1973;559-565.
37. Allgaier H., Jung G., Werner G.-G., Schneider U., Zahner H. Epidermin: sequencing of a heterodet tetracyclic 21-peptide amide antibiotic. Eur. J. Biochem. 160:1986;9-22.
38. Kellner R., Jung G., Horner T., Zahner H., Schnell N., Entian K.-D., Götz F. Gallidermin: a new lanthionine-containing polypeptide antibiotic. Eur. J. Biochem. 177:1988;53-59.
39. Mota-Meira M., Lacroix C., LaPointe G., Lavoie M.C. Purification and structure of mutacin B-Ny266: a new lantibiotic produced by Streptococcus mutans. FEBS Lett. 410:1997;275-279.
40. Hillman J.D., Novak J., Sagura E., Gutierrez J.A., Brooks T.A., Crowley P.J., Hess M., Azizi A., Leung K.-P., Cvitkovitch D., Bleiweis A.S. Genetic and biochemical analysis of mutacin 1140, a lantibiotic from Streptococcus mutans. Infect. Immun. 66:1998;2743-2749.
41. Kellner R., Jung G., Josten M., Kaletta C., Entian K.-D., Sahl H.-G. Pep5: structure elucidation of a large lantibiotic. Angew. Chem. Int. Ed. Engl. 28:1989;616-619.
42. Heidrich C., Pag U., Josten M., Metzger J., Jack R.W., Bierbaum G., Jung G., Sahl H.-G. Isolation, characterization, and heterologous expression of the novel lantibiotic epicidin 280 and analysis of its biosynthetic gene cluster. Appl. Environ. Microbiol. 64:1998;3140-3146.
43. van de Kamp M., van den Hooven H.W., Konings R.N.H., Bierbaum G., Sahl H.-G., Kuipers O.P., Siezen R.J., de Vos W.M., Hilbers C.W., van den Ven F.J.M. Elucidation of the primary structure of the lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Cloning and characterization of the epilancin K7 encoding gene and NMR analysis of mature epilancin K7. Eur. J. Biochem. 230:1995;587-600.
44. van den Hooven H.W., Lagerwerf F.M., Heerma W., Haverkamp J., Piard J.C., Hilbers C.H., Siezen R.J., Kuipers O.P., Rollema H.S. The structure of the lantibiotic lacticin 481 produced by Lactococcus lactis: location of the thioether bridges. FEBS Lett. 391:1996;317-322.
45. Gilmore M.S., Segarra R.A., Booth M.C., Bogie C.P., Hall L.R., Clewell D.B. Genetic structure of the Enterococcus faecalis plasmid pAD1-encoded cytolytic toxin system and its relationship to lantibiotic determinants. J. Bacteriol. 176:1994;7335-7344.
46. Ross K.F., Ronson C.W., Tagg J.R. Isolation and characterization of the lantibiotic salivaricin A and its structural gene salA from Streptococcus salivarius 20P3. Appl. Environ. Microbiol. 59:1993;2014-2021.
47. Mortvedt C.I., Nissen-Meyer J., Sletten K., Nes I.F. Purification and amino acid sequence of lactocin S, a bacteriocin produced by Lactobacillus sake L45. Appl. Environ. Microbiol. 57:1991;1829-1834.
48. Jack R.W., Carne A., Metzger J., Stefanovic S., Sahl H.-G., Jung G., Tagg J.R. Elucidation of the structure of SA-FF22, a lanthionine-containing antibacterial peptide produced by Streptococcus pyogenes strain FF22. Eur. J. Biochem. 220:1994;455-462.
49. Paik S.H., Chakicherla A., Hansen J.N. Identification and characterization of the structural and transporter genes for, and chemical and biological properties of, sublancin 168, a novel lantibiotic produced by Bacillus subtilis 168. J. Biol. Chem. 273:1998;23134-23142.
50. Stoffels G., Nissen-Meyer J., Guδamundsdottir A., Sletten K., Holo H., Nes I.F. Purification and characterization of a new bacteriocin isolated from a Carnobacterium spp. Appl. Environ. Microbiol. 58:1992;1417-1422.
51. Stoffels G., Guδamundsdottir A., Abee T. Membrane-associated proteins encoded by the nisin gene cluster may function as a receptor for the lantibiotic carnocin U149. Microbiology. 140:1994;1443-1450.
52. Pridmore D., Rekhif N., Pittett A.-C., Suri B., Mollet B. Variacin, a new lanthionine-containing bacteriocin produced by Micrococcus varians: comparison to lacticin 481 of Lactococcus lactis. Appl. Environ. Microbiol. 62:1996;1799-1802.
53. Minami Y., Yoshida K.-I., Azuma R., Urakawa A., Kawauchi T. Structure of cypemycin, a new peptide antibiotic. Tetrahedron Lett. 65:1994;8001-8004.
54. Benedict R.G., Dvonch W., Shotwell O.L., Pridham T.G., Lindenfelser L.A. Cinnamycin, an antibiotic from Streptomyces cinnamoneous nov. sp. Antibiot. Chemother. 2:1952;591-594.
55. Fredenhagen A., Fendrich G., Marki F., Marki W., Gruner J., Raschdorf F., Peter H.H. Duramycin B and C, two new lanthionine-containing antibiotics as inhibitors of phospholipase A2. Structural revision of duramycin and cinnamycin. J. Antibiot. Tokyo. 43:1990;1403-1412.
56. Shiba, T., Wakamiya, T., Fukase, K., Ueki, Y., Teshima, T. and Nishikawa, M. (1991) Structure of the lanthionine peptides nisin, ancovenin and lanthiopeptin. In: Nisin and Novel Lantibiotics, (Jung, G. and Sahl, H.-G., Eds.), pp. 113-122. ESCOM, Leiden.
57. Kogler, H., Bauch, M., Fehlhaber, H.-W., Griesinger, C., Schubert, W. and Teetz, V. (1991) NMR spectroscopic investigations on mersacidin. In: Nisin and Novel Lantibiotics (Jung, G. and Sahl, H.-G., Eds.), pp. 159-170. ESCOM, Leiden.
58. Kettenring J.K., Malabarba A., Vekey K., Cavalleri B. Sequence determination of actagardine, a novel lantibiotic, by homonuclear 2D NMR spectroscopy. J. Antibiot. 43:1990;1082-1088.
59. Jung, G. (1991) Lantibiotics: a survey. In: Nisin and Novel Lantibiotics (Jung, G. and Sahl, H.-G., Eds.), pp. 1-34. ESCOM, Leiden.
60. Hansen J.N. Antibiotics synthesized by post-translational modification. Annu. Rev. Microbiol. 47:1993;535-564.
61. Ingram L.C. Synthesis of the antibiotic nisin: formation of lanthionine and β-methyllanthionine. Biochim. Biophys. Acta. 184:1969;216-219.
62. Schnell N., Entian K.-D., Schneider U., Götz F., Zahner H., Kellner R., Jung G. Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide rings. Nature Lond. 333:1988;276-278.
63. Bierbaum G., Götz F., Peschel A., Kupke T., van de Kamp M., Sahl H.-G. The biosynthesis of the lantibiotics epidermin, gallidermin, Pep5 and epilancin K7. Antonie van Leeuwenhoek. 69:1996;119-127.
64. Sahl, H.-G., Reis, M., Eschbach, M., Szekat, C., Beck-Sickinger, A.G., Metzger, J., Stevanovic, S. and Jung, G. (1991) Isolation of Pep5 prepeptides in different stages of modification. In: Nisin and Novel Lantibiotics. (Jung, G. and Sahl, H.-G., Eds.), pp. 332-346. ESCOM, Leiden.
65. Skaugen M., Nissen-Meyer J., Jung G., Stevanovic S., Sletten K., Abildgaard C.I.M., Nes I.F. In vivo conversion of L-serine to D-alanine in a ribosomally synthesized polypeptide. J. Biol. Chem. 269:1994;27183-27185.
66. Kuipers O.P., Bierbaum G., Ottenwalder B., Dodd H.M., Horn N., Metzger J., Kupke T., Gnau V., Bongers R., van den Bogaard P., Kosters H., Rollema H.S., de Vos W.M., Siezen R.J., Jung G., Götz F., Sahl H.-G., Gasson M. Protein engineering of lantibiotics. Antonie van Leeuwenhoek. 69:1996;161-170.
67. Kuipers O.P., Rollema H.S., Yap W.M.G.J., Boot H.J., Siezen R.J., de Vos W.M. Engineering dehydrated amino acid residues in the antimicrobial peptide nisin. J. Biol. Chem. 267:1992;24340-24346.
68. Hurst A. Nisin. Adv. Appl. Microbiol. 27:1981;85-123.
69. Kleinhauf H., von Dohren H. Biosynthesis of peptide antibiotics. Annu. Rev. Microbiol. 41:1987;259-289.
70. Liu W., Hansen J.N. Some chemical and physical properties of nisin, a small protein antibiotic produced by Lactococcus lactis. Appl. Environ. Microbiol. 56:1990;2551-2558.
71. Chan W.C., Bycroft B.W., Lian L.-Y., Roberts G.C.K. Isolation and characterization of two degradation products derived from the peptide antibiotic nisin. FEBS Lett. 252:1989;29-36.
72. Rollema H.S., Metzger J.W., Both P., Kuipers O.P., Siezen R.J. Structure and biological activity of chemically modified nisin A species. Eur. J. Biochem. 241:1996;716-722.
73. van Kraaij C., Breukink E., Rollema H.S., Bongers R.S., Kosters H.A., de Kruijff B., Kuipers O.P. Engineering a disulphide bond and free thiols in the lantibiotic nisin Z. Eur. J. Biochem. 267:2000;901-909.
74. Chan W.C., Dodd H.M., Horn N., Maclean K., Lian L.-Y., Bycroft B.W., Gasson M.J., Roberts G.C.K. Structure-activity relationships in the peptide antibiotic nisin: role of dehydroalanine 5. Appl. Environ. Microbiol. 62:1996;2966-2969.
75. Liu W., Hansen J.N. Enhancement of the chemical and antimicrobial properties of subtilin by site-directed mutagnesis. J. Biol. Chem. 267:1992;25078-25085.
76. Jack R.W., Bierbaum G., Hiedrich C., Sahl H.-G. The genetics of lantibiotic biosynthesis. Bioessays. 17:1995;793-802.
77. Siezen R.J., Kuipers O.P., de Vos W.M. Comparison of lantibiotic gene clusters and encoded proteins. Antonie van Leeuwenhoek. 69:1996;171-184.
78. Banerjee S., Hansen J.N. Structure and expression of a gene encoding the precursor of subtilin, a small protein antibiotic. J. Biol. Chem. 263:1988;9508-9514.
79. McLaughlin R.E., Ferretti J.F., Hynes W.L. Nucleotide sequence of the streptococcin A-FF22 lantibiotic regulon: model for production of the lantibiotic SA-FF22 by strains of Streptococcus pyogenes. FEMS Microbiol. Lett. 175:1999;171-177.
80. Kaletta C., Entian K.-D., Kellner R., Jung G., Reis M., Sahl H.-G. Pep5, a new lantibiotic: structural gene isolation and prepeptide sequence. Arch. Microbiol. 152:1989;16-19.
81. Ike Y., Clewell D.B., Segarra R.A., Gilmore M.S. Genetic analysis of the pAD1 hemolysin/bacteriocin determinant in Enterococcus faecalis: Tn917 insertional mutagenesis and cloning. J. Bacteriol. 172:1990;155-163.
82. Dougherty B.A., Hill C., Weidman J.F., Richardson D.R., Venter J.C., Ross R.P. Sequence and analysis of the 60 kb conjugative, bacteriocin-producing plasmid pMRC01 from Lactococcus lactis DPC3147. Mol. Microbiol. 29:1998;1029-1038.
83. Dufour A., Rince A., Uguen P., LePennec J.P. IS1675, a novel lactococcal insertion element, forms a transposon-like structure including the lacticin 481 lantibiotic operon. J. Bacteriol. 182:2000;5600-5605.
84. Dodd H.M., Horn N., Gasson M.J. Analysis of the genetic determinant for production of the peptide antibiotic nisin. J. Gen. Microbiol. 136:1990;555-566.
85. Horn N., Swindell S., Dodd H.M., Gasson M.J. Nisin biosynthesis genes are encoded by a novel conjugative transposon. Mol. Gen. Genet. 228:1991;129-135.
86. Rodriguez J.M., Dodd H.M. Genetic determinants for the biosynthesis of nisin, a bacteriocin produced by Lactococcus lactis. Microbiol. Sem. 12:1996;61-74.
87. Rauch P.J.G., de Vos W.M. Characterization of the novel nisin-sucrose conjugative transposon Tn5276 and its insertion in Lactococcus lactis. J. Bacteriol. 174:1992;1280-1287.
88. Rauch P.J.G., Beerthuyzen M.M., de Vos W.M. Distribution and evolution of nisin-sucrose elements in Lactococcus lactis. Appl. Environ. Microbiol. 60:1994;1798-1804.
89. Reis, M. and Sahl, H.-G. (1991) Genetic analysis of the producer self-protection mechanism ('immunity') against Pep5. In: Nisin and Novel Lantibiotics (Jung, G. and Sahl, H.-G., Eds.), pp. 320-332. ESCOM, Leiden.
90. Schnell N., Engelke G., Augustin J., Rosenstein R., Ungerman V., Götz F., Entian K.-D. Analysis of genes involved in the biosynthesis of the lantibiotic epidermin. Eur. J. Biochem. 204:1992;57-68.
91. Chung Y.J., Hansen J.N. Determination of the sequence of spaE and identification of a promoter in subtilin (spa) operon in Bacillus subtilis. J. Bacteriol. 174:1992;6699-6702.
92. Engelke G., Gutowski-Eckel Z., Hammelmann M., Entian K.-D. Biosynthesis of the lantibiotic nisin: genomic organization and membrane localization of the NisB protein. Appl. Environ. Microbiol. 58:1992;3730-3743.
93. Kuipers O.P., Beerthuyzen M.M., Siezen R.J., de Vos W.M. Characterization of the nisin gene cluster nisABTCIPR of Lactococcus lactis: requirement of expression of the nisA and nisI genes for development of immunity. Eur. J. Biochem. 216:1993;281-291.
94. Ra R., Qiao M., Immonen T., Pujana I., Saris P.E.J. Genes responsible for nisin synthesis, regulation and immunity form a regulon of two operons and are induced by nisin in Lactococcus lactis. Microbiology. 142:1996;1282-1288.
95. Skaugen M., Abildgaard C.I.M., Nes I.F. Organization and expression of a gene cluster involved in the biosynthesis of the lantibiotic lactocin S. Mol. Gen. Genet. 253:1997;674-686.
96. Pag U., Heidrich C., Bierbaum G., Sahl H.-G. Molecular analysis of expression of the lantibiotic Pep5 immunity phenotype. Appl. Environ. Microbiol. 65:1999;591-598.
97. McAuliffe, O., O'Keeffe, T., Hill, C. and Ross, R.P. (2000) Regulation of immunity to the two-component lantibiotic, lacticin 3147, by the transcriptional repressor LtnR. Mol. Microbiol., in press.
98. van der Meer J.R., Polman J., Beerthuyzen M.M., Siezen R.J., Kuipers O.P., de Vos W.M. Characterization of the Lactococcus lactis nisin A operon: genes nisP, encoding a subtilisin-like serine protease involved in precursor processing, and nisR, encoding a regulatory protein involved in nisin biosynthesis. J. Bacteriol. 175:1993;2578-2588.
99. Weil H.-P., Beck-Sickinger A.G., Metzger J., Stevanovic S., Jung G., Josten M., Sahl H.-G. Biosynthesis of the lantibiotic Pep5: isolation and characterization of a prepeptide containing dehydroamino acids. Eur. J. Biochem. 194:1990;217-223.
100. Izard J.W., Kendall D.A. Signal peptides: exquisitely designed transport promoters. Mol. Microbiol. 113:1994;765-773.
101. van der Meer J.R., Rollema H.S., Siezen R.J., Beerthuyzen M.M., Kuipers O.P., de Vos W.M. Influence of amino acid substitutions in the nisin leader peptide on biosynthesis and secretion of nisin by Lactococcus lactis. J. Biol. Chem. 269:1994;3555-3562.
102. Neis S., Bierbaum G., Josten M., Pag U., Kempter C., Jung G., Sahl H.-G. Effect of leader peptide mutations on biosynthesis of the lantibiotic Pep5. FEMS Microbiol. Lett. 149:1997;249-255.
103. Håvarstein L.S., Diep D.B., Nes I.F. A family of bacteriocin ABC transporters carry out proteolytic processing of their substrates concomitant with export. Mol. Microbiol. 16:1995;229-240.
104. Siegers K., Heinzmann S., Entian K.-D. Biosynthesis of lantibiotic nisin: post-translational modification of its prepeptide occurs at a mutimeric membrane-associated lanthionine synthetase complex. J. Biol. Chem. 271:1996;12294-12301.
105. Karakas Sen A., Narbad A., Horn N., Dodd H.M., Parr A.J., Colquhoun I., Gasson M.J. Post-translational modification of nisin: the involvement of NisB in the dehydration process. Eur. J. Biochem. 261:1999;524-532.
106. Augustin J., Rosenstein R., Wieland B., Schneider U., Schnell N., Engelke G., Entian K.-D., Götz F. Genetic analysis of biosynthetic genes and epidermin-negative mutants of Staphylococcus epidermidis. Eur. J. Biochem. 204:1992;1149-1154.
107. Klein C., Kaletta C., Schnell N., Entian K.-D. Analysis of genes involved in biosynthesis of the lantibiotic subtilin. Appl. Environ. Microbiol. 58:1992;132-142.
108. Gutowski-Eckel Z., Klein C., Siegers K., Bohm K., Hammelmann M., Entian K.-D. Growth phase-dependent regulation and membrane localisation of SpaB, a protein involved in biosynthesis of the lantibiotic subtilin. Appl. Environ. Microbiol. 60:1994;1-11.
109. Peschel A., Ottenwalder B., Götz F. Inducible production and cellular location of the epidermin biosynthetic enzyme EpiB using an improved staphylococcal expression system. FEMS Microbiol. Lett. 137:1996;279-284.
110. Engelke G., Gutowski-Eckel Z., Kiesau P., Siegers K., Hammelmann M., Entian K.-D. Regulation of nisin biosynthesis and immunity in Lactococcus lactis 6F3. Appl. Environ. Microbiol. 60:1994;814-825.
111. Lavanant H., Derrick P.J., Heck A.J., Mellon F.A. Analysis of nisin A and some of its variants using Fourier transform ion cyclotron resonance mass spectrometry. Anal. Biochem. 255:1998;74-89.
112. Bierbaum G., Reis M., Szekat C., Sahl H.-G. Construction of an expression system for engineering of the lantibiotic Pep5. Appl. Environ. Microbiol. 60:1994;4332-4338.
113. van Kraaij C., Breukink E., Rollema H.S., Siezen R.J., Demel R.A., de Kruijff B., Kuipers O.P. Influence of charge differences in the C-terminal part of nisin on antimicrobial activity and signaling capacity. Eur. J. Biochem. 247:1997;114-120.
114. Kupke T., Götz F. Post-translational modifications of lantibiotics. Antonie van Leeuwenhoek. 69:1996;139-150.
115. Meyer C., Bierbaum G., Heidrich C., Reis M., Süling J., Iglesias-Wind M.I., Kempter C., Molitor E., Sahl H.-G. Nucleotide sequence of the lantibiotic Pep5 biosynthetic gene cluster and functional analysis of PepP and PepC: evidence for a role of PepC in thioether formation. Eur. J. Biochem. 232:1995;478-489.
116. Kiesau P., Eikmanns U., Gutowski-Eckel Z., Weber S., Hammelmann M., Entian K.-D. Evidence for a multimeric subtilin synthetase complex. J. Bacteriol. 179:1997;1475-1481.
117. Rince A., Dufour A., LePogam S., Thuault D., Bourgeois C.M., LePennec J.P. Cloning, expression and nucleotide sequence of genes involved in production of lactococcin DR, a bacteriocin from Lactococcus lactis subsp. lactis. Appl. Environ. Microbiol. 60:1994;1652-1657.
118. Uguen P., Le Pennec J.P., Dufour A. Lantibiotic biosynthesis: interactions between prelacticin 481 and its putative modification enzyme, LctM. J. Bacteriol. 182:2000;5262-5266.
119. McAuliffe O., Hill C., Ross R.P. Each prepeptide of the two-component lantibiotic lacticin 3147 requires a separate modification enzyme for activity. Microbiology. 146:2000;2147-2154.
120. Navaratna M.A., Sahl H.-G., Tagg J.R. Identification of genes encoding two-component lantibiotic production in Staphylococcus aureus strain C55 and other phage group II S. aureus strains and demonstration of an association with the exfoliative toxin B gene. Infect. Immun. 67:1999;4268-4271.
121. Altena K., Guder A., Cramer C., Bierbaum G. Biosynthesis of the lantibiotic mersacidin: organisation of a type-B lantibiotic gene cluster. Appl. Environ. Microbiol. 66:2000;2565-2571.
122. Kupke T., Stevanovic S., Sahl H.-G., Gotz F. Purification and characterisation of EpiD, a flavoprotein involved in the biosynthesis of the lantibiotic epidermin. J. Bacteriol. 174:1992;5354-5361.
123. Kupke T., Kempter C., Gnau V., Jung G., Gotz F. Mass spectroscopic analysis of a novel enzymatic reaction: oxidative decarboxylation of the lantibiotic precursor peptide EpiA catalyzed by the flavoprotein EpiD. J. Biol. Chem. 269:1994;5653-5659.
124. Kupke T., Götz F. In vivo reaction of affinity-tag-labelled epidermin precursor peptide with flavoenzyme EpiD. FEMS Microbiol. Lett. 153:1997;25-32.
125. Pugsley A.P. The complete general secretory pathway in Gram-negative bacteria. Microbiol. Rev. 57:1993;50-108.
126. von Heijne G. Patterns of amino acids near signal sequence cleavage sites. Eur. J. Biochem. 133:1983;17-21.
127. Kraut J. Serine proteases: structure and mechanism of catalysis. Annu. Rev. Biochem. 46:1977;331-358.
128. Geißler S., Götz F., Kupke T. Serine protease EpiP from Staphylococcus epidermidis catalyzes the processing of the epidermin precursor peptide. J. Bacteriol. 178:1996;284-288.
129. Higgins C.F. ABC transporters: from microorganisms to man. Annu. Rev. Cell Biol. 8:1992;67-113.
130. Fath M.J., Kolter R. ABC transporters: bacterial exporters. Microbiol. Rev. 57:1993;995-1017.
131. Walker J.E., Saraste M., Runswick M.J., Gay N.J. Distantly related sequences in the α- and β-subunits of ATP synthase, myosin, kinases and other ATP requiring enzymes and a common nucleotide binding fold. EMBO J. 1:1982;945-951.
132. Qiao M., Saris P.E.J. Evidence for a role of NisT in transport of the lantibiotic nisin produced by Lactococcus lactis N8. FEMS Microbiol. Lett. 144:1996;89-93.
133. Peschel A., Schnell N., Hille M., Entian K.-D., Götz F. Secretion of the lantibiotics epidermin and gallidermin: sequence analysis of the genes gdmT and gdmH, their influence on epidermin production and their regulation by EpiQ. Mol. Gen. Genet. 254:1997;312-318.
134. Marugg J.D., Gonzalez C.F., Kunka B.S., Ledeboer A.M., Pucci M.J., Toonen M.Y., Walker S.A., Zoetmudler L.C.M., Vandenbergh P.A. Cloning, expression and nucleotide sequence of genes involved in the production of pediocin PA-1, a bacteriocin from Pediococcus acidilactici PAC 1.0. Appl. Environ. Microbiol. 58:1992;2360-2367.
135. Izaguirre G., Hansen J.N. Use of alkaline phosphatase as a reporter polypeptide to study the role of the subtilin leader segment and the SpaT transporter in the post-translational modifications and secretion of subtilin in Bacillus subtilis 168. Appl. Environ. Microbiol. 63:1997;3965-3971.
136. Segarra R.A., Booth M.C., Morales D.A., Huycke M.M., Gilmore M.S. Molecular characterization of the Enterococcus faecalis cytolysin activator. Infect. Immun. 59:1991;1239-1246.
137. Gilmore M.S., Skaugen M., Nes I.F. Enterococcus faecalis cytolysin and lactocin S of Lactobacillus sake. Antonie van Leeuwenhoek. 69:1996;129-138.
138. Booth M.C., Bogie C.P., Sahl H.-G., Siezen R.J., Hatter K.L., Gilmore M.S. Structural analysis and proteolytic activation of Enterococcus faecalis cytolysin, a novel lantibiotic. Mol. Microbiol. 21:1996;1175-1184.
139. Klein C., Kaletta C., Entian K.-D. Biosynthesis of the lantibiotic subtilin is regulated by a histidine kinase/response regulator system. Appl. Environ. Microbiol. 59:1993;296-303.
140. Stock J.B., Ninfa A.J., Stock A.M. Protein phosphorylation and regulation of adaptive responses in bacteria. Microbiol. Rev. 53:1989;450-490.
141. Parkinson J.S. Signal transduction schemes of bacteria. Cell. 73:1993;857-871.
142. Kuipers O.P., Beerthuyzen M.M., de Ruyter P.G.G.A., Luesink E.J., de Vos W.M. Autoregulation of nisin biosynthesis in Lactococcus lactis by signal transduction. J. Biol. Chem. 270:1995;27299-27304.
143. Kleerebezem M., Quadri L.E.N., Kuipers O.P., de Vos W.M. Quorum-sensing by peptide pheromones and two-component signal-transduction systems in Gram-positive bacteria. Mol. Microbiol. 24:1997;895-904.
144. Peschel A., Augustin J., Kupke T., Stevanovic S., Götz F. Regulation of epidermin biosynthetic genes by EpiQ. Mol. Microbiol. 9:1993;31-39.
145. de Ruyter, P.G.G.A., 1998. Development, molecular characterisation and exploitation of the nisin controlled expression system in Lactococcus lactis, Ph.D. thesis. Wageningen Agricultural University, Wageningen.
146. McAuliffe O., Hill C., Ross R.P. Identification and overexpression of ltnI, a novel gene which confers immunity to the two-component lantibiotic, lacticin 3147. Microbiology. 146:2000;129-138.
147. Haas W., Gilmore M.S. Molecular nature of a novel bacterial toxin: the cytolysin of Enterococcus faecalis. Med. Microbiol. Immunol. 187:1999;183-190.
148. Peschel A., Gotz F. Analysis of the Staphylococcus epidermidis genes epi F, -E, and -G involved in epidermin immunity. J. Bacteriol. 178:1996;531-536.
149. Chen P., Qi F., Novak J., Caufield P.W. The specific genes for lantibiotic mutacin II biosynthesis in Streptococcus mutans T8 are clustered and can be transferred en bloc. Appl. Environ. Microbiol. 65:1999;1356-1360.
150. Abee T. Pore-forming bacteriocins of Gram-positive bacteria and self-protection mechanisms of producer organisms. FEMS Microbiol. Lett. 129:1995;1-10.
151. Saris P.E.J., Immonen T., Reis M., Sahl H.-G. Immunity to lantibiotics. Antonie van Leeuwenhoek. 69:1996;151-159.
152. Klein C., Entian K.-D. Genes involved in self-protection against the lantibiotic subtilin produced by Bacillus subtilis ATCC6633. Appl. Environ. Microbiol. 60:1994;2793-2801.
153. Reis M., Eschbach-Bludau M., Iglesias-Wind M.I., Kupke T., Sahl H.-G. Producer immunity towards the lantibiotic Pep5: identification of the immunity gene pepI and localization and functional analysis of its gene product. Appl. Environ. Microbiol. 60:1994;2876-2883.
154. Heidrich C., Pag U., Josten M., Metzger J., Jack R.W., Bierbaum G., Jung G., Sahl H.-G. Isolation, characterization, and heterologous expression of the novel lantibiotic epicidin 280 and analysis of its biosynthetic gene cluster. Appl. Environ. Microbiol. 64:1998;3140-3146.
155. Siegers K., Entian K.-D. Genes involved in immunity to the lantibiotic nisin produced by Lactococcus lactis 6F3. Appl. Environ. Microbiol. 61:1995;1082-1089.
156. Pag U., Heidrich C., Bierbaum G., Sahl H.-G. Molecular analysis of expression of the lantibiotic Pep5 immunity phenotype. Appl. Environ. Microbiol. 65:1999;591-598.
157. Qiao M., Immonen T., Koponen O., Saris P.E.J. The cellular location and effect on nisin immunity of the NisI protein from Lactococcus lactis N8 expressed in Escherichia coli and L. lactis. FEMS Microbiol. Lett. 131:1995;75-80.
158. Abel T., Maniatis T. Gene regulation: action of leucine zippers. Nature. 341:1989;24-25.
159. Rince A., Dufour A., Uguen P., Le Pennec J.-P., Haras D. Characterization of the lacticin 481 operon: the Lactococcus lactis genes lctF, lctE, and lctG encode a putative ABC transporter involved in bacteriocin immunity. Appl. Environ. Microbiol. 63:1997;4252-4260.
160. Blight M.A., Holland I.B. Structure and function of haemolysin B,P-glycoprotein and other members of a novel family of membrane translocators. Mol. Microbiol. 4:1990;873-880.
161. Otto M., Peschel A., Götz F. Producer self-protection against the lantibiotic epidermin by the ABC transporter EpiFEG of Staphylococcus epidermidis Tu3298. FEMS Microbiol. Lett. 166:1998;203-211.
162. Montville T.J., Chung H.J., Chikindas M.L., Chen Y. Nisin A depletes intracellular ATP and acts in a bactericidal manner against Mycobacterium smegmatis. Lett. Appl. Microbiol. 28:1999;189-193.
163. Holo H., Nilssen O., Nes I.F. Lactococcin A, a new bacteriocin from Lactococcus lactis subsp. cremoris isolation and characterization of the protein and its gene. J. Bacteriol. 173:1991;3879-3887.
164. van Belkum M.J., Kok J., Venema G., Holo H., Nes I.F., Konings W.N., Abee T. The bacteriocin lactococcin A specifically increases permeability of lactococcal cytoplasmic membranes in a voltage-independent, protein-mediated manner. J. Bacteriol. 173:1991;7984-7991.
165. Stevens K.A., Sheldon B.W., Klapes N.A., Klaenhammer T.R. Nisin treatment for the inactivation of Salmonella species and other Gram-negative bacteria. Appl. Environ. Microbiol. 57:1991;3613-3615.
166. Kordel M., Sahl H.-G. Susceptibility of bacterial, eukaryotic and artificial membranes to the disruptive action of the cationic peptides Pep5 and nisin. FEMS Microbiol. Lett. 34:1986;139-144.
167. Chikindas M.L., Garcia-Garcera M.J., Driessen A.J.M., Ledeboer A.M., Nissen-Meyer J., Nes I.F., Abee T., Konings W.N., Venema G. Pediocin PA-1, a bacteriocin from Pediococcus acidilactici PAC1.0 forms hydrophilic pores in the cytoplasmic membrane of target pores. Appl. Environ. Microbiol. 59:1993;3577-3584.
168. Abee T., Klaenhammer T.R., Letellier L. Kinetic studies of the action of lacticin F, a bacteriocin produced by Lactobacillus johnsonii that forms poration complexes in the cytoplasmic membrane. Appl. Environ. Microbiol. 60:1994;1006-1013.
169. Gonzalez B., Glaasker E., Kunji E.R.S., Driessen A.J.M., Suarez J.E., Konings W.N. Bactericidal mode of action of plantaricin C. Appl. Environ. Microbiol. 62:1996;2701-2709.
170. Moll G., Ubbink-Kok T., Hildeng-Hauge H., Nissen-Myer J., Nes I.F., Konings W.N., Driessen A.J.M. Lactococcin G is a potassium ion-conducting, two-component bacteriocin. J. Bacteriol. 178:1996;600-605.
171. Montville T.J., Bruno M.E.C. Evidence that dissipation of proton motive force is a common mechanism of action for bacteriocins and other antimicrobial proteins. Int. J. Food. Microbiol. 24:1994;53-74.
172. Harold, F.M. (1986) The Vital Force: A Study of Bioenergetics. W.H. Freeman, New York.
173. Sahl H.-G., Kordel M., Benz R. Voltage-dependent depolarization of bacterial membranes and artificial lipid bilayers by the peptide antibiotic nisin. Arch. Microbiol. 149:1987;120-124.
174. Benz, R., Jung, G. and Sahl, H.-G. (1991) Mechanism of channel-forming lantibiotics in black lipid membranes. In: Nisin and Novel Lantibiotics. (Jung, G. and Sahl, H.-G., Eds.), pp. 359-372. ESCOM, Leiden.
175. Bruno M.E.C., Montville T.J. Common mechanistic action of bacteriocins from lactic acid bacteria. Appl. Environ. Microbiol. 59:1993;3003-3010.
176. Garcia-Garcera M.J., Elferink M.G.L., Driessen A.J.M., Konings W.N. In vitro pore-forming activity of the lantibiotic nisin: role of protonmotive-force and lipid composition. Eur. J. Biochem. 212:1993;417-422.
177. McAuliffe O., Ryan M.P., Ross R.P., Hill C., Breeuwer P., Abee T. Lacticin 3147, a broad-spectrum bacteriocin which selectively dissipates the membrane potential. Appl. Environ. Microbiol. 64:1998;439-445.
178. Breukink E., Wiedemann I., van Kraaij C., Kuipers O.P., Sahl H.-G., de Kruijff B. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science. 286:1999;2361-2364.
179. Breukink E., de Kruijff B. The lantibiotic nisin, a special case or not? Biochim. Biophys. Acta. 1462:1999;223-234.
180. Brotz H., Bierbaum G., Reynolds P.E., Sahl H.-G. The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation. Eur. J. Biochem. 246:1997;193-199.
181. Ruhr E., Sahl H.-G. Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on artificial membrane vesicles. Antimicrob. Agents Chemother. 27:1985;841-845.
182. Kordel M., Benz R., Sahl H.-G. Mode of action of the staphylococcin-like peptide Pep5: voltage-dependent depolarisation of bacterial and artificial membranes. J. Bacteriol. 170:1988;84-88.
183. Schuller F., Benz R., Sahl H.-G. The peptide antibiotic subtilin acts by formation of voltage-dependent multi-state pores in bacterial and artificial membranes. Eur. J. Biochem. 182:1989;181-186.
184. Jack R.W., Benz R., Tagg J.R., Sahl H.-G. The mode of action of SA-FF22, a lantibiotic from Streptococcus pyogenes strain FF22. Eur. J. Biochem. 219:1994;699-705.
185. Reisinger P., Seidel H., Tschesche H., Hammes W.P. The effect of nisin on murein synthesis. Arch. Microbiol. 127:1980;187-193.
186. Abee T., Rombouts F.M., Hugenholtz J., Guihard G., Letellier L. Mode of action of nisin Z against Listeria monocytogenes Scott A grown at high and low temperatures. Appl. Environ. Microbiol. 60:1994;1962-1968.
187. Okereke A., Montville T.J. Nisin dissipates the proton motive force of the obligate anaerobe Clostridium sporogenes PA3679. Appl. Environ. Microbiol. 58:1992;2463-2467.
188. Bruno M.E.C., Kaiser A., Montville T.J. Depletion of the proton motive force by nisin in Listeria monocytogenes cells. Appl. Environ. Microbiol. 58:1992;2255-2259.
189. Driessen A.J.M., van den Hooven H.W., Kuiper W., van de Kemp M., Sahl H.-G., Konings R.N.H., Konings W.N. Mechanistic studies of lantibiotic-induced permeabilization of phospholipid vesicles. Biochemistry. 34:1995;1606-1614.
190. Kordel M., Schuller F., Sahl H.-G. Interaction of the pore forming-peptide antibiotics Pep5, nisin and subtilin with non-energized liposomes. FEBS Lett. 244:1989;99-102.
191. Abee, T., Gao, F.H. and Konings, W.N. (1991) The mechanism of action of the lantibiotic nisin in artificial membranes. In: Nisin and Novel Lantibiotics (Jung, G. and Sahl, H.-G., Eds.), pp. 373-385. ESCOM, Leiden.
192. Gao F.H., Abee T., Konings W.N. Mechanism of action of the peptide antibiotic nisin in liposomes and cytochrome c oxidase-containing proteoliposomes. Appl. Environ. Microbiol. 57:1991;2164-2170.
193. Martin I., Ruysschaert J.M., Sanders D., Giffard C. Interaction of the lantibiotic nisin with membranes revealed by fluorescence quenching of an introduced tryptophan. Eur. J. Biochem. 239:1996;156-164.
194. Breukink E., van Kraaij C., Demel R.A., Siezen R.J., Kuipers O.P., de Kruijff B. The C-terminal region of nisin is responsible for the initial interaction of nisin with the target membrane. Biochemistry. 36:1997;6968-6976.
195. Demel R.A., Peelen T., Siezen R.J., de Kruijff B., Kuipers O.P. Nisin Z, mutant nisin Z and lacticin 481 interactions with anionic lipids correlate with antimicrobial activity: a monolayer study. Eur. J. Biochem. 235:1996;267-274.
196. Moll G.N., Clark J., Chan W.C., Bycroft B.W., Roberts G.C.K., Konings W.N., Driessen A.J.M. Role of transmembrane pH gradient and membrane binding in nisin pore formation. J. Bacteriol. 179:1997;135-140.
197. Bierbaum G., Sahl H.-G. Induction of autolysis of staphylococci by the basic peptide antibiotics Pep5 and nisin and their influence on the activity of autolytic enzymes. Arch. Microbiol. 141:1985;249-254.
198. Ghuysen J.-M. Use of bacteriolytic enzymes in determination of wall structure and their role in cell metabolism. Bacteriol. Rev. 32:1968;425-464.
199. Bierbaum G., Sahl H.-G. Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase. J. Bacteriol. 169:1987;5452-5458.
200. Bierbaum G., Sahl H.-G. Influence of cationic peptides on the activity of the autolytic endo-β-N-acetylglucosaminidase of Staphylococcus simulans 22. FEMS Microbiol. Lett. 58:1988;223-228.
201. Bierbaum, G. and Sahl, H.-G. (1991) Induction of autolysis of Staphylococcus simulans 22 by Pep5 and nisin and influence of the cationic peptides on the activity of the autolytic enzymes. In: Nisin and Novel Lantibiotics (Jung, G. and Sahl, H.-G., Eds.), pp. 386-396. ESCOM, Leiden.
202. Moll G.N., Roberts G.C.K., Konings W.N., Driessen A.J.M. Mechanism of lantibiotic-induced pore-formation. Antonie van Leeuwenhoek. 69:1996;185-191.
203. Jack, R.W., Bierbaum, G. and. Sahl, H.-G. (1997) Lantibiotics and related peptides. Springer-Verlag, New York.
204. Ojcius D.M., Young J.D. Cytolytic pore-forming proteins and peptides: is there a common structural motif? Trends Biochem. Sci. 16:1991;225-229.
205. Moll G.N., Konings W.N., Driessen A.J.M. The lantibiotic nisin induced transmembrane movement of a fluorescent phospholipid. J. Bacteriol. 180:1998;6565-6570.
206. Bruekink E., van Kraaij C., van Dalen A., Demel R.A., Siezen R.J., de Kruijff B., Kuipers O.P. The orientation of nisin in membranes. Biochemistry. 37:1998;8153-8162.
207. Bechinger B. Structure and functions of channel-forming peptides: magainins, cecropins, melittin and alamethicin. J. Membr. Biol. 156:1997;197-211.
208. van Kraaij C., Breukink E., Noordermeer M.A., Demel R., Siezen R.J., de Kruijff B., Kuipers O.P. Pore formation by nisin involves the translocation of its C-terminal part across the membrane. Biochemistry. 37:1998;16033-16040.
209. Matsuzaki K., Murase O., Fujii N., Miyajima K. Translocation of a channel-forming antimicrobial peptide, magainin 2, across lipid bilayers by forming a pore. Biochemistry. 34:1995;6521-6526.
210. Brotz H., Sahl H.-G. New insights into the mechanism of action of lantibiotics-diverse biological effects by binding to the same molecular target. J. Antimicrob. Chemother. 46:2000;1-6.
211. Brotz H., Josten M., Wiedemann I., Schneider U., Gotz F., Bierbaum G., Sahl H.-G. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol. Microbiol. 30:1998;317-327.
212. Wiedemann, I., Breukink, E., van Kraaij, C., Kuipers, O.P., Bierbaum, G., de Kruijff, B. and Sahl, H.-G. (2000) Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity, J. Biol. Chem.
213. Liu W., Hansen J.N. The antimicrobial effect of outgrowing of Bacillus cereus T spores and vegetative cells occurs by different mechanisms. Appl. Environ. Microbiol. 59:1993;648-651.
214. Kido Y., Hamakado T., Yoshida T., Anno M., Motoki Y., Wakamiya T., Shiba T. Isolation and characterization of ancovenin, a new inhibitor of angiotensin I converting enzyme, produced by actinomycetes. J. Antibiot. Tokyo. 36:1983;1295-1299.
215. Fredenhagen A., Fendrich G., Marki F., Marki W., Gruner J., Raschdorf F., Peter H.H. Duramycin B and C, two new lanthionine-containing antibiotics as inhibitors of phospholipase A2. Structural revision of duramycin and cinnamycin. J. Antibiot. Tokyo. 43:1990;1403-1412.
216. Zimmermann N., Freund S., Fredenhagen A., Jung G. Solution structure of the lantibiotics duramycin B and C. Eur. J. Biochem. 216:1993;419-428.
217. Navarro J., Chabot J., Sherrill K., Aneja R., Zahler S.A., Packer E. Interaction of duramycin with artificial and natural membranes. Biochemistry. 24:1985;4645-4650.
218. Chen L.L., Tai P.C. Effect of antibiotics and other inhibitors on ATP-dependent protein translocation into membrane vesicles. J. Bacteriol. 169:1987;2372-2379.
219. Sheth T.R., Henderson R.M., Hladky S.B., Cuthbert A.W. Ion channel formation by duramycin. Biochim. Biophys. Acta. 1107:1992;179-185.
220. Choung S.-Y., Hobayashi T., Takemoto K., Ishitsuka H., Inoue K. Haemolytic activity of a cyclic peptide RO 09-0198 isolated from Streptoverticillium. Biochim. Biophys. Acta. 940:1988;171-179.
221. Dunkley E.A. Jr., Slejan S., Guffanti A.A., Krulwich T.A. Large decreases in membrane phosphotidylethanolamine and diphosphatidylglycerol upon mutation to duramycin resistance do not change the protonophore resistance of Bacillus subtilis. Biochim. Biophys. Acta. 943:1988;13-18.
222. Clejan S., Guffanti A.A., Cohen M.A., Krulwich T.A. Mutations of Bacillus firmus OF4 to duramycin resistance results in substantial replacement of membrane lipid phosphotidylethanolamine by its plasmalogen form. J. Bacteriol. 171:1989;1744-1746.
223. Marki F., Hanni E., Fredenhagen A., van Oostrum J. Mode of action of the lanthionine-containing peptide antibiotics duramycin, duramycin B, duramycin C and cinnamycin as direct inhibitors of phospholipase A2. Biochem. Pharmacol. 42:1991;2027-2035.
224. Chatterjee S., Chatterjee D.K., Jani R.H., Blumbach J., Ganguli B.N., Klesel N., Limbert M., Seibert G. Mersacidin, a new antibiotic from Bacillus: in vitro and in vivo antibacterial activity. J. Antibiot. 45:1992;839-845.
225. Brotz H., Bierbaum G., Markus A., Molitor E., Sahl H.-G. Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism? Antimicrob. Agents Chemother. 39:1995;714-719.
226. Brotz H., Bierbaum G., Leopold K., Reynolds P.E., Sahl H.-G. The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II. Antimicrob. Agents Chemother. 42:1998;154-160.
227. Nagarajan R. Antibacterial activities and modes of action of vancomycin and related glycopeptides. Antimicrob. Agents Chemother. 35:1991;605-609.
228. Niu W.-W., Neu H.C. Activity of mersacidin, a novel peptide, compared with that of vancomycin, teicoplanin, and daptomycin. Antimicrob. Agents Chemother. 35:1991;998-1000.
229. Marciset O., Jeronimus-Stratingh M.C., Mollet B., Poolman B. Thermophilin 13, a nontypical antilisterial poration complex bacteriocin that functions without a receptor. J. Biol. Chem. 272:1997;14277-14284.
230. Moll G.N., Hildeng-Hauge H., Nissen-Meyer J., Nes I.F., Konings W.N., Driessen A.J.M. Mechanistic properties of the two-component bacteriocin lactococcin G. J. Bacteriol. 180:1998;96-99.
231. Allison G.E., Fremaux C., Klaenhammer T.R. Expansion of bacteriocin activity and host range upon complementation of two peptides encoded within the lacticin F operon. J. Bacteriol. 176:1994;2235-2241.
232. Tahara T., Oshimura M., Umezawa C., Kanatani K. Isolation, partial characterization, and mode of action of acidocin J1132, a two-component bacteriocin produced by Lactobacillus acidophilus JCM 1132. Appl. Microbiol. Environ. 62:1996;892-897.
233. Ross R.P., Galvin M., McAuliffe O., Morgan S.M., Ryan M.P., Twomey D.P., Meaney W.J., Hill C. Developing applications for lactococcal bacteriocins. Antonie van Leeuwenhoek. 76:1999;337-346.